The use of myocardial scintigraphy with thallium-199 for diagnosis of ischemic heart disease and assessment of efficacy of antianginal therapy

V. I. Chernov, V. F. Mordovin, S. V. Triss, N. A. Fedorova, E. Yu Kolomin, Zh V. Vesnina, A. Yu Fedorov, R. S. Karpov, Yu B. Lishmanov

Research output: Contribution to journalArticle

Abstract

The aim of the stidy was to investigate diagnostic value of myocardial scintigraphy with a new short living radionuclide 199TI for detection of myocardual ischemia and to elucidate the potential of this method for assessment of effects of calcium antagonists on myocardial perfusion in patients with ischemic heart disease. Myocardial scintigraphy was performed in 160 patients (105 patients with ischemic heart disease and 55 controls). In 51 patients scintigraphy was done before and after treatment with calcium antagonists. Myocardial scintigraphy with 199TI had high sentitivity (93%) and specificity (84%) for diagnosis of ischemic heart disease. Frequency of detection of perfusion defects directly depended on number of obstructed coronary arteries and on presence of postinfarction cardiosclerosis. Reduction of size of transient perfusion defects during treatment with calcium antagonists (isradipine, diltiazem, long acting verapamil) was observed in more that 50% of patients. Positive effect of these drugs on myocardial perfusion diminished with increase in number of obstructed vessels and in X-syndrome. In 20% of patients with ischemic heart disease therapy ith blockers of calcium channels was associated with expansion of zones of hypoperfusion without negative dynamics of clinical state. The latter fact made the use of myocardial perfusion scintigraphy especially important for the control of treatment with calcium anragonists.

Original languageEnglish
Pages (from-to)60-63
Number of pages4
JournalKardiologiya
Volume36
Issue number8
Publication statusPublished - 1996

Fingerprint

Myocardial Perfusion Imaging
Thallium
Myocardial Ischemia
Perfusion
Calcium
Therapeutics
Isradipine
Perfusion Imaging
Diltiazem
Calcium Channel Blockers
Verapamil
Radioisotopes
Radionuclide Imaging
Coronary Vessels
Ischemia
Pharmaceutical Preparations

Keywords

  • Calcium antagonists
  • Ischemic heart disease, radionuclide stidies
  • Myocardial perfusion
  • Myocardial scintigraphy
  • Thallium-199
  • X-syndrome

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Chernov, V. I., Mordovin, V. F., Triss, S. V., Fedorova, N. A., Kolomin, E. Y., Vesnina, Z. V., ... Lishmanov, Y. B. (1996). The use of myocardial scintigraphy with thallium-199 for diagnosis of ischemic heart disease and assessment of efficacy of antianginal therapy. Kardiologiya, 36(8), 60-63.

The use of myocardial scintigraphy with thallium-199 for diagnosis of ischemic heart disease and assessment of efficacy of antianginal therapy. / Chernov, V. I.; Mordovin, V. F.; Triss, S. V.; Fedorova, N. A.; Kolomin, E. Yu; Vesnina, Zh V.; Fedorov, A. Yu; Karpov, R. S.; Lishmanov, Yu B.

In: Kardiologiya, Vol. 36, No. 8, 1996, p. 60-63.

Research output: Contribution to journalArticle

Chernov, VI, Mordovin, VF, Triss, SV, Fedorova, NA, Kolomin, EY, Vesnina, ZV, Fedorov, AY, Karpov, RS & Lishmanov, YB 1996, 'The use of myocardial scintigraphy with thallium-199 for diagnosis of ischemic heart disease and assessment of efficacy of antianginal therapy', Kardiologiya, vol. 36, no. 8, pp. 60-63.
Chernov, V. I. ; Mordovin, V. F. ; Triss, S. V. ; Fedorova, N. A. ; Kolomin, E. Yu ; Vesnina, Zh V. ; Fedorov, A. Yu ; Karpov, R. S. ; Lishmanov, Yu B. / The use of myocardial scintigraphy with thallium-199 for diagnosis of ischemic heart disease and assessment of efficacy of antianginal therapy. In: Kardiologiya. 1996 ; Vol. 36, No. 8. pp. 60-63.
@article{a605c074d6bd4f77aa89cf3f6eee812e,
title = "The use of myocardial scintigraphy with thallium-199 for diagnosis of ischemic heart disease and assessment of efficacy of antianginal therapy",
abstract = "The aim of the stidy was to investigate diagnostic value of myocardial scintigraphy with a new short living radionuclide 199TI for detection of myocardual ischemia and to elucidate the potential of this method for assessment of effects of calcium antagonists on myocardial perfusion in patients with ischemic heart disease. Myocardial scintigraphy was performed in 160 patients (105 patients with ischemic heart disease and 55 controls). In 51 patients scintigraphy was done before and after treatment with calcium antagonists. Myocardial scintigraphy with 199TI had high sentitivity (93{\%}) and specificity (84{\%}) for diagnosis of ischemic heart disease. Frequency of detection of perfusion defects directly depended on number of obstructed coronary arteries and on presence of postinfarction cardiosclerosis. Reduction of size of transient perfusion defects during treatment with calcium antagonists (isradipine, diltiazem, long acting verapamil) was observed in more that 50{\%} of patients. Positive effect of these drugs on myocardial perfusion diminished with increase in number of obstructed vessels and in X-syndrome. In 20{\%} of patients with ischemic heart disease therapy ith blockers of calcium channels was associated with expansion of zones of hypoperfusion without negative dynamics of clinical state. The latter fact made the use of myocardial perfusion scintigraphy especially important for the control of treatment with calcium anragonists.",
keywords = "Calcium antagonists, Ischemic heart disease, radionuclide stidies, Myocardial perfusion, Myocardial scintigraphy, Thallium-199, X-syndrome",
author = "Chernov, {V. I.} and Mordovin, {V. F.} and Triss, {S. V.} and Fedorova, {N. A.} and Kolomin, {E. Yu} and Vesnina, {Zh V.} and Fedorov, {A. Yu} and Karpov, {R. S.} and Lishmanov, {Yu B.}",
year = "1996",
language = "English",
volume = "36",
pages = "60--63",
journal = "Kardiologiya",
issn = "0022-9040",
publisher = "Media Sfera",
number = "8",

}

TY - JOUR

T1 - The use of myocardial scintigraphy with thallium-199 for diagnosis of ischemic heart disease and assessment of efficacy of antianginal therapy

AU - Chernov, V. I.

AU - Mordovin, V. F.

AU - Triss, S. V.

AU - Fedorova, N. A.

AU - Kolomin, E. Yu

AU - Vesnina, Zh V.

AU - Fedorov, A. Yu

AU - Karpov, R. S.

AU - Lishmanov, Yu B.

PY - 1996

Y1 - 1996

N2 - The aim of the stidy was to investigate diagnostic value of myocardial scintigraphy with a new short living radionuclide 199TI for detection of myocardual ischemia and to elucidate the potential of this method for assessment of effects of calcium antagonists on myocardial perfusion in patients with ischemic heart disease. Myocardial scintigraphy was performed in 160 patients (105 patients with ischemic heart disease and 55 controls). In 51 patients scintigraphy was done before and after treatment with calcium antagonists. Myocardial scintigraphy with 199TI had high sentitivity (93%) and specificity (84%) for diagnosis of ischemic heart disease. Frequency of detection of perfusion defects directly depended on number of obstructed coronary arteries and on presence of postinfarction cardiosclerosis. Reduction of size of transient perfusion defects during treatment with calcium antagonists (isradipine, diltiazem, long acting verapamil) was observed in more that 50% of patients. Positive effect of these drugs on myocardial perfusion diminished with increase in number of obstructed vessels and in X-syndrome. In 20% of patients with ischemic heart disease therapy ith blockers of calcium channels was associated with expansion of zones of hypoperfusion without negative dynamics of clinical state. The latter fact made the use of myocardial perfusion scintigraphy especially important for the control of treatment with calcium anragonists.

AB - The aim of the stidy was to investigate diagnostic value of myocardial scintigraphy with a new short living radionuclide 199TI for detection of myocardual ischemia and to elucidate the potential of this method for assessment of effects of calcium antagonists on myocardial perfusion in patients with ischemic heart disease. Myocardial scintigraphy was performed in 160 patients (105 patients with ischemic heart disease and 55 controls). In 51 patients scintigraphy was done before and after treatment with calcium antagonists. Myocardial scintigraphy with 199TI had high sentitivity (93%) and specificity (84%) for diagnosis of ischemic heart disease. Frequency of detection of perfusion defects directly depended on number of obstructed coronary arteries and on presence of postinfarction cardiosclerosis. Reduction of size of transient perfusion defects during treatment with calcium antagonists (isradipine, diltiazem, long acting verapamil) was observed in more that 50% of patients. Positive effect of these drugs on myocardial perfusion diminished with increase in number of obstructed vessels and in X-syndrome. In 20% of patients with ischemic heart disease therapy ith blockers of calcium channels was associated with expansion of zones of hypoperfusion without negative dynamics of clinical state. The latter fact made the use of myocardial perfusion scintigraphy especially important for the control of treatment with calcium anragonists.

KW - Calcium antagonists

KW - Ischemic heart disease, radionuclide stidies

KW - Myocardial perfusion

KW - Myocardial scintigraphy

KW - Thallium-199

KW - X-syndrome

UR - http://www.scopus.com/inward/record.url?scp=3342984838&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3342984838&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 60

EP - 63

JO - Kardiologiya

JF - Kardiologiya

SN - 0022-9040

IS - 8

ER -